Researchers Have Discovered the First Effective Treatment for a Rare Blood Vessel Disorder
The trial of pomalidomide for treating hereditary hemorrhagic telangiectasia was halted early due to positive results. A clinical trial has shown that the cancer drug pomalidomide is both safe and…